Original Source(s)
Related Content
10 CMS and FDA Actions Affecting Care in 2026
From Medicare payment updates to drug approvals and device access, these federal actions may affect reimbursement, prescribing, patient access, and clinical workflows.
July 10, 2026
-
7 min
FDA Expands Gene Therapy for Younger Patients
Exagamglogene autotemcel is now indicated for patients aged 2 years and older with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.
July 2, 2026
-
3 min